Bicycle Therapeutics (BCYC) Leases: 2019-2025
Historic Leases for Bicycle Therapeutics (BCYC) over the last 7 years, with Sep 2025 value amounting to $4.6 million.
- Bicycle Therapeutics' Leases fell 49.82% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year decrease of 49.82%. This contributed to the annual value of $7.7 million for FY2024, which is 41.73% down from last year.
- Per Bicycle Therapeutics' latest filing, its Leases stood at $4.6 million for Q3 2025, which was down 21.43% from $5.8 million recorded in Q2 2025.
- In the past 5 years, Bicycle Therapeutics' Leases registered a high of $18.7 million during Q1 2023, and its lowest value of $3.2 million during Q3 2021.
- Moreover, its 3-year median value for Leases was $10.9 million (2024), whereas its average is $10.8 million.
- As far as peak fluctuations go, Bicycle Therapeutics' Leases spiked by 1,036.90% in 2021, and later slumped by 49.82% in 2025.
- Over the past 5 years, Bicycle Therapeutics' Leases (Quarterly) stood at $14.7 million in 2021, then dropped by 6.87% to $13.7 million in 2022, then declined by 3.58% to $13.2 million in 2023, then crashed by 41.73% to $7.7 million in 2024, then slumped by 49.82% to $4.6 million in 2025.
- Its Leases was $4.6 million in Q3 2025, compared to $5.8 million in Q2 2025 and $6.7 million in Q1 2025.